SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-21-000051
Filing Date
2021-02-22
Accepted
2021-02-22 16:06:28
Documents
20
Period of Report
2021-02-18
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rvnc-20210218.htm   iXBRL 8-K 54084
2 EX-99.1 rvncq420er8-k_exhibit991.htm EX-99.1 149009
3 EX-99.2 rvncq420er8-k_exhibit992.htm EX-99.2 20209
4 EX-99.3 rvncq420er8-k_exhibit993.htm EX-99.3 36958
10 image_01.jpg GRAPHIC 15763
11 image_01b.jpg GRAPHIC 15763
12 newrevancelogo1.jpg GRAPHIC 11936
  Complete submission text file 0001479290-21-000051.txt   495667

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rvnc-20210218.xsd EX-101.SCH 2458
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rvnc-20210218_cal.xml EX-101.CAL 744
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rvnc-20210218_def.xml EX-101.DEF 1689
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rvnc-20210218_lab.xml EX-101.LAB 24275
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rvnc-20210218_pre.xml EX-101.PRE 12680
13 EXTRACTED XBRL INSTANCE DOCUMENT rvnc-20210218_htm.xml XML 11331
Mailing Address 7555 GATEWAY BLVD NEWARK CA 94560
Business Address 1222 DEMONBREUN STREET SUITE 1001 NASHVILLE TN 37203 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 21660273
SIC: 2834 Pharmaceutical Preparations